Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Offer for Subscription - Update

8 Nov 2017 09:00

RNS Number : 8460V
Baronsmead Second Venture Trust PLC
08 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

8 November 2017

Offer for Subscription - Update

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (before costs) (the "Offer"). The Company announced on 26 October 2017 that it had raised gross proceeds of approximately £13.5 million pursuant to the Offer and accordingly had issued 13,797,365 New Shares at an Offer Price of 97.60 pence.

The Board of the Company is now pleased to announce that as at the close of business on 7 November 2017, the Company had raised gross proceeds of approximately £16.5 million in total pursuant to the Offer.

The Board has resolved to move the second allotment of New Shares under the Offer from 15 November 2017 to 17 November 2017 to allow Existing Shareholders and new investors additional time to submit their Subscription Forms. The Company will make a further announcement in relation to the second allotment, including the Offer Price at which the New Shares will be issued, in due course. In accordance with the terms of the Offer the Board has further resolved to extend the Offer period to 12 noon on 29 December 2017 or until such date as the Offer is fully subscribed, being no later than 29 December 2017.

Subscriptions will be processed by the Receiving Agent on a "first come, first served" basis. Existing Shareholders and new investors who wish to participate in the Offer should return a completed Subscription Form to the Receiving Agent, as set out in the Prospectus, as soon as possible.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPUBVBRBRAARAA
Date   Source Headline
27th Jun 20255:49 pmRNSTransaction in Own Shares
18th Jun 20254:25 pmRNSAllotment of Shares and Total Voting Rights
17th Jun 20257:00 amRNSChange of Allotment Date
11th Jun 20257:00 amRNSHalf-year Report
5th Jun 202512:00 pmRNSNet Asset Value(s)
2nd Jun 20252:19 pmRNSTotal Voting Rights
28th May 202510:20 amRNSClose of Offer to New Applications
7th May 20253:45 pmRNSNet Asset Value(s)
1st May 202511:10 amRNSAllotment of Shares and Total Voting Rights
29th Apr 20254:15 pmRNSNet Asset Value(s)
25th Apr 202512:04 pmRNSEXTENSION OF THE OFFER
3rd Apr 20252:06 pmRNSAllotment of Shares and Total Voting Rights
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20252:36 pmRNSDirector/PDMR Shareholding
13th Mar 20254:16 pmRNSEXTENSION OF THE OFFER
13th Mar 20259:00 amRNSResult of AGM
6th Mar 20253:30 pmRNSNet Asset Value(s)
4th Mar 20255:19 pmRNSTotal Voting Rights
4th Mar 20255:14 pmRNSTransaction in Own Shares
3rd Mar 202511:07 amRNSTotal Voting Rights
26th Feb 20255:30 pmRNSTransaction in Own Shares
24th Feb 20252:01 pmRNSQuarterly Factsheet
21st Feb 20251:09 pmRNSOffer Update:Close of Early Subscription Incentive
20th Feb 20255:19 pmRNSDirector/PDMR Shareholding
20th Feb 20255:19 pmRNSDirector/PDMR Shareholding
20th Feb 20252:30 pmRNSAllotment of Shares and Total Voting Rights
6th Feb 20253:30 pmRNSNet Asset Value(s)
27th Jan 20252:00 pmRNSNet Asset Value(s)
10th Jan 202512:16 pmRNSPublication of Prospectus/Offer for Subscription
3rd Jan 20253:51 pmRNSDirector Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
24th Dec 20247:00 amRNSAnnual Financial Report
19th Dec 20244:23 pmRNSTransaction in Own Shares
12th Dec 20249:51 amRNSDirector Declaration
5th Dec 20249:45 amRNSNet Asset Value(s)
2nd Dec 202410:14 amRNSTotal Voting Rights
26th Nov 20242:00 pmRNSUpdate on Offer for Subscription
22nd Nov 20247:00 amRNSCompliance with UK Market Abuse Regulation
18th Nov 20246:16 pmRNSTransaction in Own Shares
8th Nov 202412:30 pmRNSNet Asset Value(s)
31st Oct 202410:00 amRNSNet Asset Value(s)
22nd Oct 20244:28 pmRNSNewsletter H2 2024
21st Oct 202410:38 amRNSDirectorate Change
1st Oct 20247:00 amRNSIntention To Fundraise
26th Sep 20243:34 pmRNSDirector/PDMR Shareholding
23rd Sep 20244:20 pmRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSQuarterly Factsheet
5th Sep 20244:30 pmRNSNet Asset Value(s)
2nd Sep 202410:55 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.